$RLAY
Relay Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$18.84
▼-1.82%-$0.350
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateRelay Therapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is RLAY down today? It is at $18.84 (-1.82%), and our scanner flagged it 132 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RLAY spikes, and full due diligence on RLAY — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RLAY 132 times in the last 30 days. Create a free account to track $RLAY, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RLAY from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RLAY today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystRelay Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 9, 2026 · 11 days ago| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Patel Sanjiv Officer | Sold (automatic/other) | -48K 0.02% of company | sold 8.5% | 520K | $913K at $18.94 | Sep 8, 26 |
Catinazzo Thomas Officer | Sold (automatic/other) | -18K | sold 13% | 123K | $336K at $18.94 | Sep 8, 26 |
Bergstrom Donald A Officer | Sold (automatic/other) | -9K | sold 2.1% | 399K | $162K at $18.97 | Sep 8, 26 |
Rahmer Peter Officer | Sold (automatic/other) | -5K | sold 2.0% | 224K | $90K at $20.03 | Aug 26, 26 |
Svf Pauling (Cayman) Ltd Beneficial Owner (10%) | Sold (automatic/other) | -6.00M 2.7% of company | sold 22% | 21.90M | $116.4M at $19.40 | Aug 25, 26 |
Patel Sanjiv Officer | Sold (automatic/other) | -48K 0.02% of company | sold 7.8% | 568K | $980K at $20.33 | Aug 17, 26 |
Catinazzo Thomas Officer | Sold (automatic/other) | -18K | sold 11% | 141K | $350K at $19.74 | Aug 14, 26 |
Bergstrom Donald A Officer | Sold (automatic/other) | -2K | sold 0.5% | 408K | $42K at $18.61 | Jul 28, 26 |
Rahmer Peter Officer | Sold (automatic/other) | -748 | sold 0.3% | 228K | $14K at $18.61 | Jul 28, 26 |
Catinazzo Thomas Officer | Sold (automatic/other) | -1K | sold 0.9% | 158K | $27K at $18.61 | Jul 28, 26 |
Patel Sanjiv Officer | Sold (automatic/other) | -48K 0.02% of company | sold 7.3% | 616K | $944K at $19.58 | Jul 7, 26 |
Catinazzo Thomas Officer | Sold (automatic/other) | -18K | sold 10.0% | 160K | $331K at $18.69 | Jul 6, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in biological products, (no diagnostic substances), closest in size first.
Here is the latest on RLAY from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RLAY today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RLAY last traded at $18.84, down 1.82% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Relay Therapeutics, Inc. Common Stock (RLAY) is next expected to report earnings on Thursday, November 5, 2026, about 46 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RLAY Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RLAY 132 times in the last 30 days.
RLAY (Relay Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $4.13B in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RLAY for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RLAY discussion
Sign in to ask a question or join the discussion.